Modern psychiatry defines disorders by a checklist of symptoms (e.g., via the DSM), treating the syndrome itself as the disease. This is unlike the rest of medicine, which views symptoms like a cough as signals of various underlying causes. This flawed approach has stalled progress by focusing on labels instead of mechanisms.

The Broader Autism Phenotype (BAP) refers to people with subclinical autistic traits who don't qualify for a diagnosis. These individuals often share traits that lead them to gravitate towards the same fields (e.g., engineering) and social circles as autistic people.

Individuals are claiming conditions like autism to create a unique identity, similar to 'stolen valor.' This trend diminishes the struggles of those with genuine diagnoses and uses the condition as a social crutch or excuse.

The next wave of neuroscience therapeutics is shifting from managing broad symptoms (e.g., in autism) to precision therapies. By identifying genetic underpinnings of a disease, developers can create drugs that target the specific biology of patient subpopulations, aiming for disease modification rather than just symptomatic relief.

A diagnosis like autism may function like the 19th-century term 'dropsy' (swelling). It accurately describes a collection of symptoms but doesn't necessarily identify a single, unified underlying cause. The label captures a surface-level phenomenon, not a fundamental 'thing' in the world.

Instead of a categorical disease model (virus present/absent), mental health should adopt a dimensional approach like internal medicine. Just as blood pressure exists on a spectrum, psychological traits do too. Treatment decisions can be based on evidence-backed cutoffs for risk, eliminating the need for arbitrary diagnostic boxes.

Societies that rely on unspoken social cues inherently disadvantage autistic people. By contrast, communities with explicit, written-down rules eliminate ambiguity and create a more accessible environment where neurodivergent individuals can participate on equal footing without fear of misinterpreting subtle norms.

The autism "spectrum" is not a single line from less to more autistic. It is a multi-dimensional space with various clusters of traits, akin to a "10-dimensional spectrum." This complexity leads some researchers to prefer the term "autisms" to reflect this heterogeneity.

Before the DSM, psychiatric disease definitions were bespoke to different schools of thought. The DSM's great achievement was creating a common diagnostic umbrella. While imperfect, this standardization was a crucial foundational step for the field to begin communicating and researching consistently.